| Financial Year |
March 31 2023 |
| Monetary Funds |
1,066,248,282.06 |
| Held-for-trading Financial Assets |
383,519,090.69 |
| Notes Receivable |
69,338,294.72 |
| Accounts Receivable |
985,961,959.66 |
| Advances to Suppliers |
110,489,560.60 |
| Other Receivables |
101,253,877.72 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
534,095,224.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
623,387,859.49 |
| Total Current Assets |
3,874,294,149.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,976,005.61 |
| Investment Properties |
5,312,111.68 |
| Fixed Assetes |
233,369,443.51 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
197,936,724.21 |
| R&D expenses |
-- |
| Goodwill |
463,085,667.00 |
| Long-Term Deferred and Prepaid Expenses |
5,707,718.77 |
| Deferred Income Tax Assets |
61,927,962.02 |
| Other Non-Current Assets |
15,463,960.06 |
| Sub-Total of Non-Current Assets |
1,118,510,686.81 |
| Total Assets |
4,992,804,836.01 |
| Short-Term Loans |
57,057,675.04 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
324,835,610.59 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
30,377,615.77 |
| Taxes Payable |
11,340,011.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
374,322,582.47 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
36,719,451.13 |
| Other Current Liabilities |
55,385,321.32 |
| Sub-Total of Current Liabilities |
1,111,417,452.70 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
37,800.00 |
| Deferred Income Tax Liabilities |
39,151,767.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
97,935,948.28 |
| Total Liabilities |
1,209,353,400.98 |
| Paid-In Capital(Or Share Stock) |
305,783,097.00 |
| Capital Surplus |
3,088,758,547.58 |
| Surplus Reserve |
152,247,987.03 |
| LESS:Treasury Stock |
19,762,869.00 |
| Undistributed Profits |
1,160,193,740.02 |
| Minority Stockholder's Interest |
460,556,644.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,322,894,791.00 |
| Owner's Equity（Stockholder's Equity） |
3,783,451,435.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,992,804,836.01 |
